AI assistant
Sending…
Enveric Biosciences, Inc. — Director's Dealing 2018
Aug 22, 2018
35460_dirs_2018-08-22_cc1da0fb-cadb-4983-a0aa-9201ef3d3e39.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMERI Holdings, Inc. (AMRH)
CIK: 0000890821
Period of Report: 2018-08-20
Reporting Person: LUCI DAVID P (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-20 | Option (Right to Buy) | $1.53 | A | 150000 | Acquired | Common Stock (150000) | Direct | |
| 2018-08-20 | Restricted Stock Unit | $ | A | 15000 | Acquired | Common Stock (15000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2430 | Direct |
Footnotes
F1: The options vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders of the Issuer occurring after August 16, 2018. The options will expire on the fifth anniversary of the vesting date.
F2: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
F3: The Restricted Stock Units vest on the first anniversary of the grant date.
More from Enveric Biosciences, Inc.
Share Issue/Capital Change
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 4
Report Publication Announcement
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 30
Capital/Financing Update
2026
Apr 29
Regulatory Filings
2026
Apr 23